Search
Close this search box.

Za pregled sadržaja potrebno je prijaviti se kao postojeći ili novi korisnik.

Izgubili ste lozinku?

Održana predavanja na ESH Course-u, održanom 11. i 12.ožujka 2022. godine možete pregledati u nastavku.

Po završetku pregleda molimo Vas da ispunite kratki upitnik u linku OVDJE.

Sadržaj programa

GENERAL INTRODUCTION
  • President of the Slovene Society of Hypertension, J. BRGULJAN HITIJ (Slovenia)
  • President of the Croatian Society of Hypertension, B. JELAKOVIC (Croatia) 
  • President of the European Society of Hypertension, R. KREUTZ (Germany)

HYPERTENSION SESSIONS

AMBULATORY BLOOD PRESSURE MEASUREMENT

Chairpersons: J. BRGULJAN HITIJ (Slovenia), R. KREUTZ (Germany)

  • Introduction R. KREUTZ (Germany)
  • 2021 ESH Practice Guidelines for Office and out-of-office BP measurement (20’) G. STERGIOU (Greece)
  • ABPM in daily practice through cases: P. DOLENC (Slovenia)
  • Upgrade in ABPM with “SOMNOtouch”?: A. JELAKOVIC (Croatia)
  • 24-hour CABP measurement: V. PRELEVIC (Croatia-Monte Negro)
  • Case presentations: 24-hour CABP/PWV: M. DOMISLOVIC (Croatia) & J. KNEZ (Slovenia)
  • Panel discussion
  • Conclusion: J. BRGULJAN HITIJ (Slovenia)

HYPERTENSION SESSIONS

NEW FACTS IN ANTIHYPERTENSIVE TREATMENT

Chairpersons: G. MANCIA (Italy), G. STERGIOU (Greece)

  • Introduction: G. MANCIA (Italy)
  • Chronotherapy in hypertension: M. BURNIER (Switzerland)
  • Case presentation: chronotherapy: J. RADIC (Croatia)
  • How to choose the right treatment for better long-term
    prognosis: J. BRGULJAN HITIJ (Slovenia)
  • Case presentations: season variability and
    office-to-office variability: A. JELAKOVIC (Croatia) & T. PETRESKI (Slovenia)
  • Prevalence and distribution of CABP hypertension in
    general population (EH-UH 2 study): B. JELAKOVIC (Croatia)
  • Panel discussion
  • Conclusion: G. STERGIOU (Greece)

GENERAL SESSION

PATIENTS ARE ACTORS OF THEIR DISEASE

Chairpersons: B. JELAKOVIC (Croatia), M. BURNIER (Switzerland)

  • Introduction: M. BURNIER (Switzerland)
  • Psychological aspects of chronic patients: M. PRETNAR SILVESTER (Slovenia)
  • Communication with chronic patients: A. PATHAK (Monaco)
  • Panel discussion
  • Conclusion: B. JELAKOVIC (Croatia)

COVID-19 SESSION

WHAT DID WE LEARN ABOUT COVID-19 AND CV DISEASES – LATEST UPDATES

Chairpersons: J. BRGULJAN HITIJ (Slovenia), A. PATHAK (Monaco)

  • Introduction: A. PATHAK (Monaco)
  • Hypertension during the COVID-19 pandemic: R. KREUTZ (Germany)
  • Antihypertensive treatment and COVID-19: G. MANCIA (Italy)
  • Country clinical experience – HT & COVID-19: L. GELLINEO (Croatia) & M. PENKO (Slovenia)
  • Cardiovascular complications in COVID-19: C. TSIOUFIS (Greece)
  • Country experience: CV diseases during COVID-19 pandemic and digital platform for HCPs: A. CERNE CERCEK (Slovenia) & S. KARANOVIC (Croatia)
  • Panel discussion
  • Conclusion: J. BRGULJAN HITIJ (Slovenia)

SESSION ON ANGINA PECTORIS & DYSLIPIDAEMIA

MANAGEMENT OF PATIENTS WITH HIGH CV RISK: CHRONIC CORONARY SYNDROME (CCS) AND/OR DYSLIPIDAEMIA

Chairpersons: C. TSIOUFIS (Greece), I. PECIN (Croatia), L. LIPAR (Slovenia)

  • Introduction: C. TSIOUFIS (Greece)
  • Acting Simultaneously on Coronary Arteries and Cardiomyocytes in CCS: L. LIPAR (Slovenia)
  • Case presentations: CCS patient with microvascular AP and CCS patient with successful PCI but still symptomatic: S. DANOJEVIC (Slovenia) & M. PUSNIK VRCKOVNIK (Slovenia)
  • AP discussion
  • Are we forgetting combined approach in treating hypertension and dyslipidaemia?: I. PECIN (Croatia)
  • Case presentations: CCS patient with dyslipidaemia and diabetic patient with dyslipidaemia: M. PAVLOV (Croatia) & T. TURK WENSVEEN (Croatia)
  • Dyslipidaemia discussion
  • Conclusion: C. TSIOUFIS (Greece)
GENERAL CONCLUSION
  • President of the European Society of Hypertension, R. KREUTZ (Germany)
  • President of the Croatian Society of Hypertension, B. JELAKOVIC (Croatia) 
  • President of the Slovene Society of Hypertension, J. BRGULJAN HITIJ (Slovenia)